From: Mouse models of sarcomas: critical tools in our understanding of the pathobiology
Tumor type | Gene alteration(s) | Agent used | Significance | Proposed karyotype | Reference |
---|---|---|---|---|---|
Synovial Sarcoma | SYT-SSX2 fusion | Myf 5-Cre | Expression of the SYT-SSX2 transgene resulted in 100% penetrant synovial sarcomas | Translocation | |
Myxoid Liposarcoma | TLS-CHOP fusion w/ p53 deletion | Prx-Cre | Deletion of p53 cooperates in the formation of liposarcomas | Translocation | [62] |
Neurofibroma MPNST | NF1 deletion w or w/o p53 and p19Arf deletions | Germline, POa-Cre, or 3.9Periostin-Cre | Deletion of p53 and p19Arf stimulate MPNST development | Complex | |
Uterine leiomyosarcoma | Lmp2 deletion | None | Loss of Lmp2 results in uterine leiomyosarcoma formation | Complex | |
Uterine leiomyosarcoma | TDGF1/CRIPTO overexpression | MMTV-promoter | TDGF1/CRIPTO expression results in uterine leiomyosarcoma development | Complex | [67] |